Title |
Diagnostic delay in hidradenitis suppurativa is a global problem
|
---|---|
Published in |
British Journal of Dermatology, November 2015
|
DOI | 10.1111/bjd.14038 |
Pubmed ID | |
Authors |
D.M. Saunte, J. Boer, A. Stratigos, J.C. Szepietowski, I. Hamzavi, K.H. Kim, K. Zarchi, C. Antoniou, L. Matusiak, H.W. Lim, M. Williams, H.H. Kwon, M.A. Gürer, F. Mammadova, A. Kaminsky, E. Prens, H.H. van der Zee, V. Bettoli, S. Zauli, J. Hafner, S. Lauchli, L.E. French, H. Riad, M. El‐Domyati, H. Abdel‐Wahab, B. Kirby, G. Kelly, P. Calderon, V. del Marmol, F. Benhadou, J. Revuz, C.C. Zouboulis, I. Karagiannidis, K. Sartorius, L. Hagströmer, E. McMeniman, N. Ong, M. Dolenc‐Voljc, Z.B. Mokos, L. Borradori, R.E. Hunger, C. Sladden, N. Scheinfeld, N. Moftah, L. Emtestam, J. Lapins, N. Doss, I. Kurokawa, G.B.E. Jemec |
Abstract |
DM Saunte was paid as a consultant for advisory board meeting by AbbVie and as a speaker for Bayer, Galderma, Astellas, and Leo Pharma. A Stratigos was paid as a consultant for board meetings, speaker and received a research grant as an investigator for AbbVie, MSD and Pfizer. JC Szepietowski was paid as a consultant and speaker for Abbvie. I Hamzavi received investigator grants from MicroDermis and AbbVie. This article is protected by copyright. All rights reserved. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 2 | 40% |
Ireland | 1 | 20% |
Unknown | 2 | 40% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 3 | 60% |
Science communicators (journalists, bloggers, editors) | 2 | 40% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 198 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Other | 23 | 12% |
Student > Bachelor | 18 | 9% |
Student > Master | 17 | 9% |
Researcher | 16 | 8% |
Student > Doctoral Student | 14 | 7% |
Other | 32 | 16% |
Unknown | 78 | 39% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 80 | 40% |
Nursing and Health Professions | 5 | 3% |
Pharmacology, Toxicology and Pharmaceutical Science | 5 | 3% |
Agricultural and Biological Sciences | 4 | 2% |
Biochemistry, Genetics and Molecular Biology | 4 | 2% |
Other | 15 | 8% |
Unknown | 85 | 43% |